Gene · 51
Papers2,671
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,671
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Occurrence and fate of Adsorbable Organic Halogens (AOX) in two WWTPs from Romania. | Arch Environ Contam Toxicol | 2022 | 35435442 | PubTator, text mining | PubMed |
| The Metabolic Impact of Two Different Parenteral Nutrition Lipid Emulsions in Children after Hematopoietic Stem Cell Transplantation: A Lipidomics Investigation. | Int J Mol Sci | 2022 | 35409026 | PubTator, text mining | PubMed |
| RNA Editing in Glioma as a Sexually Dimorphic Prognostic Factor That Affects mRNA Abundance in Fatty Acid Metabolism and Inflammation Pathways. | Cells | 2022 | 35406793 | PubTator, text mining | PubMed |
| Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease. | Cells | 2022 | 35406730 | PubTator, text mining | PubMed |
| Oxygenating Biocatalysts for Hydroxyl Functionalisation in Drug Discovery and Development. | ChemMedChem | 2022 | 35385205 | PubTator, text mining | PubMed |
| Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism. | Mol Metab | 2022 | 35381388 | PubTator, text mining | PubMed |
| Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway. | Sci Rep | 2022 | 35379885 | PubTator, text mining | PubMed |
| A touch-based multimodal and cryptographic bio-human-machine interface. | Proc Natl Acad Sci U S A | 2022 | 35377784 | PubTator, text mining | PubMed |
| Maternal Sodium p-Perfluorous Nonenoxybenzene Sulfonate Exposure Disturbed Lipid Metabolism and Induced an Imbalance in Tyrosine Metabolism in the F1 Generation of Mice. | Chem Res Toxicol | 2022 | 35377151 | PubTator, text mining | PubMed |
| Redox Homeostasis in Cardiovascular Disease: The Role of Mitochondrial Sirtuins. | Front Endocrinol (Lausanne) | 2022 | 35370975 | PubTator, text mining | PubMed |
| Dietary Phosphorus Reduced Hepatic Lipid Deposition by Activating Ampk Pathway and Beclin1 Phosphorylation Levels to Activate Lipophagy in Tilapia Oreochromis niloticus. | Front Nutr | 2022 | 35369063 | PubTator, text mining | PubMed |
| What physiological role(s) does the alternative oxidase perform in animals? | Biochim Biophys Acta Bioenerg | 2022 | 35367450 | PubTator, text mining | PubMed |
| Modulation of Plasma Proteomic Profile by Regular Training in Male and Female Basketball Players: A Preliminary Study. | Front Physiol | 2022 | 35360242 | PubTator, text mining | PubMed |
| MicroRNA-31: a pivotal oncogenic factor in oral squamous cell carcinoma. | Cell Death Discov | 2022 | 35351880 | PubTator, text mining | PubMed |
| Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice. | Cell Death Dis | 2022 | 35351852 | PubTator, text mining | PubMed |
| Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1/p-LKB-1/AMPK, HMGCR & PPAR-α signaling pathways. | J Ethnopharmacol | 2022 | 35351574 | PubTator, text mining | PubMed |
| Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model. | J Clin Invest | 2022 | 35349482 | PubTator, text mining | PubMed |
| System-level metabolic modeling facilitates unveiling metabolic signature in exceptional longevity. | Aging Cell | 2022 | 35343058 | PubTator, text mining | PubMed |
| Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models. | Int J Mol Sci | 2022 | 35328587 | PubTator, text mining | PubMed |
| SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection. | Int J Mol Sci | 2022 | 35328527 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51/papers?page=37